BioAmber signs off-take agreement for bio-based BDO, hedging future risks

BioAmber recently signed a 15-year take-or-pay agreement for bio-based 1,4-butanediol (BDO) with Vinmar International. Under the terms of the contract, Vinmar is to purchase 100% of the BDO produced by BioAmber’s 100,000 tpy planned production facility, which is expected to commence production in...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Shin-Etsu Chemical to invest $28 million in new production for mmWave materials

News Commentary | December 04, 2020

This is likely the same material licensed from Novoset in January 2020. The first phase will have a production capacity of 80 tons a year, which is in line with our prediction of a total market size of around 2,000 tons of demand in 2021. Look for Shin‑Etsu Chemical and others to quickly ramp up ... Not part of subscription

Braskem is investing $61 million to expand bio-based ethylene capacity to 260 ktpa

News Commentary | March 02, 2021

This announcement is considered a delay of plans, as the company initially intended to double its capacity after a few years of production over a decade ago. The delay results from the slow‑growing demand for Braskem's materials, as their higher costs have limited their use to niche products. Brands... Not part of subscription

Hindenburg gets it right: Beware of investing in PureCycle

Analyst Insight | May 24, 2021

Hindenburg Research, a notable short seller with scathing reports on Nikola and Loop Industries, has once again set its attention on the advanced recycling space by releasing a damning report on American solvent‑based recycler PureCycle Technologies. Once again, we break down Hindenburg's claims and... Not part of subscription